References
- Bent S., Tiedt T. N., Odden M. C., Shlipak M. G. The relative safety of ephedra compared with other herbal products. Annals of Internal Medicine 2003; 138(6)468–472
- Burger M. IPCS INTOX databank. 2000, http://www.intox.org/databank/documents/pharm/ephedrin/pim209.htm#PartTitle:1.%20%20NAME Retrieved November 10, 2005, from
- Gurley B. J., Wang P., Gardner S. F. Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-huang) as determined by high performance liquid chromatography. Journal of Pharmacological Sciences 1998; 87: 1547–1553
- Haller C. A., Benowitz N. L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. New England Journal of Medicine 2000; 343: 1833
- Labao L. M. Locality and inequality: Farm and industry structure and socioeconomic conditions. State University of New York Press, Albany, NY 1990
- Liang K. Y., Zeger S. L. Regression analysis for correlated data. Annual Review of Public Health 1993; 14: 43–68
- National Center on Addiction and Substance Abuse. No place to hide: Substance abuse in mid-size cities and rural America. Columbia University, New York 2000
- Preston D. B., Mansfield P. K. Assessing the health states of rural people: An analysis of American studies 1980–1985. Advances in health education and promotion, W. Ward, F. Lewis. JAI Press, Greenwich, CT 1990
- Shekelle P., Morton S., Maglione M., et al. Ephedra and ephedrine for weight loss and athletic performance enhancement: Clinical efficacy and side effects. Agency for Healthcare Research and Quality, Rockville, MD 2003, Evidence Report/Technology Assessment No. 76 (prepared by Southern California Evidence-based Practice Center, RAND, under Contract No. 209-97-0001, Task Order No. 9). (AHRQ Publication No. 03-EO22
- Swaim R. C., Beauvais F., Chavez E. L., Oetting E. R. The effect of school dropout rates on estimates of adolescent substance use among three racial/ethnic groups. American Journal of Public Health 1997; 87(1)51–55
- The American Association of Poison Control Centers Toxic Exposure Surveillance System, http://www.aapcc.org/Annual%20Reports/02report/Annual%20Report%202002.pdf 2002 Annual Report. Retrieved 2003, from
- U.S. Food and Drug Administration. Consumer alert: FDA plans regulation prohibiting sale of ephedra-containing dietary supplements and advises consumers to stop using these products. 2003a, http://www.fda.gov/oc/initiatives/ephedra/december2003/advisory.html Retrieved January 2004, from
- U.S. Food and Drug Administration. Evidence on the safety and effectiveness of ephedra: Implications for regulation. 2003b, http://www.fda.gov/bbs/topics/NEWS/ephedra/whitepaper.html FDA White Paper on Ephedra. Retrieved September 2, 2003, from